Chapter 22 Role of ATP-Sensitive Potassium Channels in Ischemia/Reperfusion-Induced Ventricular Arrhythmias

Current Topics in Membranes and Transport

Volumn 46, Issue C, 1999, Pages 417-434

  Arita, Makoto ^a   Shigematsu, Sakuji ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1242303684     PISSN: 00702161     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2161(08)60938-7     Document Type: Article

References (32)

1. + channels protect the myocardium against ischemia/reperfusion damage. Cir. Res. 69 (1991) 571-581
2. Cook N.S., and Quast U. Potassium channels: Structure, classification, function and therapeutic potential. In: Cook N.S. (Ed). Potassium Channel Pharmacology (1990), Ellis Harwood, Chester, U.K. 181-255
3. Echt D.S., Liebson R.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., Arensberg D., Barker A., Friedman L., Greene H.L., Huther M.L., and Richardson D.W. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trials. N. Engl. J. Med. 324 (1991) 781-788
4. Gachot B.A., Bazier M., Cherrier J.F., and Daubeze J. Cibenzoline and hypoglyce-mia. Lancet 2 (1988) 280
5. Goldberg I.J., Brown L.K., and Rayfeld E.J. Disopyramide (Norpace®) increased hypoglycemia. Am. J. Med. 69 (1980) 463-466
6. Gross G.J., and Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70 (1992) 223-233
7. Hillemann D.E., Mohiuddin S.M., and Ahmed I.S. Cibenzoline-induced hypoglycemia. Drug. Intell. Clin. Pharm. 21 (1987) 38-89
8. Horie M., Ishida-Taka A., Ai T., Nishimoto T., Tsuura Y., Ishida H., Seino Y., and Sasayama S. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs. Cardiovasc. Res. 34 (1997) 69-72
9. Inomata N., Ishihara T., and Akaika N. SUN1165: A new antiarrhythmic Na current blocker in ventricular myocytes of guinea-pig. Comp. Biochem. Physiol. 87C (1987) 237-243
10. Kempsford R.D., and Hawgood B.J. Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion. Eur. J. Pharmacol. 163 (1989) 61-68
11. Kimura J., Miyamae S., and Noma A. Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig. J. Physiol. (London) 384 (1987) 199-222
12. Krause S.M., and Gess M.L. Characterization of cardiac sarcoplasmic reticulum dysfunction during short-term normothermic global ischemia. Circ. Res. 55 (1985) 176-184
13. 2+ activation as a consequence of reperfusiem-induced cellular calcium overload in ferret hearts. J. Clin. Invest. 79 (1987) 950-961
14. Liu J.-X., Tanonaka K., Ohtsuka Y., Sasaki Y., and Takeo S. Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic drugs. J. Pharmacol. Exp. Ther. 266 (1993) 1247-1254
15. McCullough J.R., Normandin D.E., Conder M.L., Sleph P.G., Dzwonczyk S., and Grover G.J. Specific block of the anti-ischemic actions of cromakalim by sodium-5-hydroxy-decanoate. Circ. Res. 69 (1991) 949-958
16. Millar J.S., and Vaugham Williams E.M. Effects on rabbit nodal, atria, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia. Br. J. Pharmacol. 75 (1982) 469-478
17. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
18. Murry C.E., Richard V.J., Jennings R.B., and Reimer K.A. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am. J. Physiol. 260 (1991) H796-H804
19. Nakamura S., Kiyosue T., and Arita M. Glucose reverses 2.4-dinitrophenol induced changes in action potentials and membrane currents of guinea pig ventricular cells via enhanced glycolysis. Cardiovasc, Res. 23 (1989) 286-294
20. Nichols C.G., Ripoll C., and Lederer W.J. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Cir. Res. 68 (1991) 280-287
21. + channels in cardiac muscle. Nature (London) 305 (1983) 147-148
22. Rothbart S.T., and Saksena S. Clinical electrophysiology efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia. Am. J. Cardiol. 57 (1986) 941-946
23. + channels in guinea-pig ventricular cells. Br. J. Pharmacol. 108 (1993) 549-556
24. Sato T., Shigematsu S., and Arita M. Mexiletine-induced shortening of the action potential duration of ventricular muscles by activation of ATP-sensiive K+ channels. Br. J. Pharmacol. 115 (1995) 381-382
25. + channel: A comparison with pinacidil and lemakalim. Circ. Res. 69 (1991) 1152-1158
26. 2+ concentration during depolarization in heart muscle. Am. J. Physiol. 250 (1986) C651-C656
27. Shigematsu S., and Arita M. Anoxia-induced activation of ATP-sensitive K+ channels in guinea pig ventricular cells and its modulation by glycolysis. Cardiovasc. Res. 35 (1997) 273-282
28. + channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation 92 (1995) 2266-2275
29. Wang D.W., Sato T., and Arita M. Voltage dependent inhibition of ATP-sensitive potassium channels by flecainide in guinea pig ventricular cells. Cardiovasc. Res. 29 (1995) 520-525
30. Wilde A.A.M., and Janse M.J. Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogensis. Cardiovasc. Res. 28 (1994) 16-24
31. Wu B., Sato T., Kiyosue T., and Arita M. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhyth-mic drugs. Cardiovasc. Res. 26 (1992) 1095-1101
32. Zipes D.P., and Troup P.J. New antiarrhythmicagents. Am. J. Cardiol. 41 (1987) 1005-1024